InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
1.820
+0.110 (6.43%)
Mar 20, 2026, 2:08 PM EDT - Market open
InspireMD Revenue
In the year 2025, InspireMD had annual revenue of $8.98M with 28.11% growth. InspireMD had revenue of $3.15M in the quarter ending December 31, 2025, with 61.57% growth.
Revenue (ttm)
$8.98M
Revenue Growth
+28.11%
P/S Ratio
8.91
Revenue / Employee
$136,045
Employees
66
Market Cap
85.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.98M | 1.97M | 28.11% |
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | 3.72M | 120.00K | 3.33% |
| Dec 31, 2018 | 3.60M | 840.00K | 30.42% |
| Dec 31, 2017 | 2.76M | 867.00K | 45.78% |
| Dec 31, 2016 | 1.89M | -416.00K | -18.01% |
| Dec 31, 2015 | 2.31M | -508.00K | -18.03% |
| Dec 31, 2014 | 2.82M | -3.30M | -53.95% |
| Dec 31, 2013 | 6.12M | 115.00K | 1.92% |
| Dec 31, 2011 | 6.00M | 1.06M | 21.32% |
| Dec 31, 2010 | 4.95M | 1.54M | 45.09% |
| Dec 31, 2009 | 3.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 212.69M |
| Neuronetics | 149.16M |
| Xtant Medical Holdings | 133.08M |
| Outset Medical | 119.48M |
| LENSAR | 59.14M |
| MaxCyte | 34.42M |
| Baird Medical Investment Holdings | 31.86M |
| Sensus Healthcare | 27.48M |
NSPR News
- 2 days ago - InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 11 days ago - InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - GlobeNewsWire
- 4 months ago - Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - GlobeNewsWire
- 4 months ago - InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript - Seeking Alpha